Vanguard Group’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.7M | Sell |
3,124,693
-91,194
| -3% | -$926K | ﹤0.01% | 2334 |
|
|
2025
Q1 | $17.9M | Buy |
3,215,887
+12,098
| +0.4% | +$67.5K | ﹤0.01% | 2558 |
|
|
2024
Q4 | $25.9M | Buy |
3,203,789
+36,478
| +1% | +$294K | ﹤0.01% | 2462 |
|
|
2024
Q3 | $32.5M | Sell |
3,167,311
-32,415
| -1% | -$332K | ﹤0.01% | 2369 |
|
|
2024
Q2 | $22.6M | Buy |
3,199,726
+317,671
| +11% | +$2.25M | ﹤0.01% | 2511 |
|
|
2024
Q1 | $39.6M | Buy |
2,882,055
+629,536
| +28% | +$8.66M | ﹤0.01% | 2268 |
|
|
2023
Q4 | $20.7M | Sell |
2,252,519
-336,350
| -13% | -$3.09M | ﹤0.01% | 2581 |
|
|
2023
Q3 | $15.7M | Buy |
2,588,869
+791,843
| +44% | +$4.79M | ﹤0.01% | 2651 |
|
|
2023
Q2 | $13.9M | Buy |
1,797,026
+153,952
| +9% | +$1.19M | ﹤0.01% | 2763 |
|
|
2023
Q1 | $9.37M | Buy |
1,643,074
+96,789
| +6% | +$552K | ﹤0.01% | 2971 |
|
|
2022
Q4 | $9.11M | Buy |
1,546,285
+199,423
| +15% | +$1.17M | ﹤0.01% | 2993 |
|
|
2022
Q3 | $4.31M | Sell |
1,346,862
-66,869
| -5% | -$214K | ﹤0.01% | 3400 |
|
|
2022
Q2 | $6.33M | Sell |
1,413,731
-230,288
| -14% | -$1.03M | ﹤0.01% | 3244 |
|
|
2022
Q1 | $8.78M | Buy |
1,644,019
+13,981
| +0.9% | +$74.7K | ﹤0.01% | 3222 |
|
|
2021
Q4 | $24M | Buy |
1,630,038
+31,116
| +2% | +$457K | ﹤0.01% | 2744 |
|
|
2021
Q3 | $33.4M | Buy |
1,598,922
+365,052
| +30% | +$7.63M | ﹤0.01% | 2587 |
|
|
2021
Q2 | $21.8M | Sell |
1,233,870
-21,337
| -2% | -$377K | ﹤0.01% | 2791 |
|
|
2021
Q1 | $30.8M | Buy |
1,255,207
+387,656
| +45% | +$9.5M | ﹤0.01% | 2578 |
|
|
2020
Q4 | $29.4M | Buy |
867,551
+441,385
| +104% | +$14.9M | ﹤0.01% | 2463 |
|
|
2020
Q3 | $10.7M | Sell |
426,166
-2,548
| -0.6% | -$63.7K | ﹤0.01% | 2751 |
|
|
2020
Q2 | $14.5M | Buy |
+428,714
| New | +$14.5M | ﹤0.01% | 2582 |
|